Effect of GLP-1 medications on gum disease treatment
Part of Hormones & metabolism, Mouth & dental clinical trials.
This study looks at whether taking GLP-1 medications (commonly used for diabetes or weight loss) can improve gum health and the response to standard non-surgical gum disease treatment. If you are on a GLP-1 drug and have gum disease, this trial may help determine if your treatment works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old
- Your body mass index (BMI) must be 25 or higher (overweight or obese)
- You need at least 20 of your natural teeth present
- You must have gum disease (periodontitis)
- You need to be taking a GLP-1 medication (like Ozempic, Wegovy, or similar) for at least 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a class of drugs called GLP-1 receptor agonists, used for type 2 diabetes and obesity, affect your saliva and oral health. If you are new to this medication, you may help us understand its benefits and risks for your mouth.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
This trial is testing whether a GLP-1 receptor agonist (a medicine used for diabetes) helps treat gum disease (periodontitis) in people with type 2 diabetes. It might show that this medication improves gum health as a side benefit.
This study looks at how weight-loss medications (GLP-1 drugs) might affect your saliva and teeth. If you're starting one of these medications, the study will check your mouth health before you start and again after 3 months.
This study looks at how gum inflammation and certain genetic changes relate to obesity. It may help explain why obesity affects oral health, and could lead to better ways to prevent or treat gum disease.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.